6th Annual Platelet Colloquium (2011) Print

6th Annual Platelet Colloquium (2011)

January 13-15, 2011
Willard InterContinental Hotel
Washington, DC

Overarching Themes

The overarching theme for the Platelet Colloquium’s 6th annual program is the translation of fundamental scientific concepts underlying circulatory and device-associated vascular injury to the management of patients receiving cardiac device therapy. A bench-to-bedside forum will feature basic science insights dedicated to platelet receptor activation, inflammatory cell biology, endothelial dysregulation, and the effects of biomechanical stress on coagulation and hemostatic proteins. These constructs will collectively be translated, in the context of prior and ongoing clinical trials, to better determine the pathobiology and overall incidence of adverse events and their attenuation, modulation and prevention through findings derived from the investigation of patients receiving cardiac devices.

Objectives

Objective 1: To gain a better understanding of the role of platelets in the response to cardiovascular device-associated injury.

Objective 2: To describe the relationship between mechanical cardiac devices, shear stress and alterations in platelet biology and function.

Objective 3: To review existing evidence derived from in vitro, in vivo, and clinical investigations supporting therapies to modify platelet- associated responses to device-related injury.

Agenda

icon Click here for the 6th Annual Platelet Colloquium agenda.

Grants

Educational grants or support were provided by the following companies:

  • Abbott Laboratories (Abbott Vascular)
  • AstraZeneca
  • Boston Scientific Corporation
  • Daiichi Sankyo, Inc. and Lilly USA, LLC
  • Medtronic CardioVascular
  • Regado Biosciences, Inc.
  • St. Jude Medical
  • The Medicines Company